NEW HORIZONS IN LARYNGEAL CANCER TREATMENT

Authors
  • Xatamov Sh. N

    Ph.D, Asian International University
Abstract
Laryngeal cancer, a malignancy affecting the voice box, presents a significant healthcare challenge. Traditional treatment approaches, including surgery, radiation therapy, and chemotherapy, have yielded varying degrees of success, often accompanied by significant side effects that impact a patient's quality of life. However, recent advancements in medical science are heralding a new era of hope for individuals diagnosed with this disease. One of the most promising breakthroughs lies in the realm of targeted therapies. These innovative treatments work by precisely targeting specific molecules or pathways involved in cancer cell growth and proliferation. Unlike traditional chemotherapy, which indiscriminately attacks both cancerous and healthy cells, targeted therapies minimize damage to normal tissues, resulting in fewer side effects. Another exciting development is the emergence of immunotherapy. This revolutionary approach harnesses the power of the body's own immune system to fight cancer. By stimulating the immune system to recognize and attack cancer cells, immunotherapy offers the potential for long-lasting remissions and improved survival rates. The future of laryngeal cancer treatment is bright. With ongoing research and clinical trials, we can expect to see even more innovative therapies emerge in the years to come, offering new hope and improved outcomes for patients battling this disease.
References

1. National Comprehensive Cancer Network (NCCN). Head and Neck Cancers. Version 2.2024.

2. Forastiere AA, Goepfert H, Maor M, et al. Concurrent chemotherapy and radiation therapy for organ preservation in advanced laryngeal cancer. N Engl J Med. 2003;349(22):2091-2098.

3. Lydiatt WM, Patel SG, O'Sullivan B, et al. Head and Neck cancers-comprehensive management. Springer; 2010.

4. WHO Classification of Tumours Editorial Board. Head and Neck Tumours. Lyon: IARC Press; 2017.